Johnson & Johnson (JNJ) EBT Margin (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of EBT Margin data on file, last reported at 24.89% in Q1 2026.

• Quarterly EBT Margin fell 3737.0% year-over-year to 24.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25.88% (down 390.0% YoY) and the FY2025 annual result came in at 34.59%, up 1580.0% from the prior year.
• EBT Margin improved to 24.89% in Q1 2026 per JNJ's latest filing, from 20.22% in the prior quarter.
• The five-year high for EBT Margin was 62.26% in Q1 2025, with the low at 6.16% in Q2 2023.
• Average EBT Margin over 5 years is 24.0%, with a median of 24.89% recorded in 2026.
• Year-over-year, EBT Margin jumped 4489 bps in 2025 and plunged 3737 bps in 2026.
• Johnson & Johnson's EBT Margin stood at 25.87% in 2022, then decreased by 13 bps to 22.56% in 2023, then fell by 23 bps to 17.26% in 2024, then climbed by 17 bps to 20.22% in 2025, then rose by 23 bps to 24.89% in 2026.
• Business Quant data shows JNJ's EBT Margin at 24.89% in Q1 2026, 20.22% in Q4 2025, and 31.23% in Q3 2025.